Literature DB >> 16809284

Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein.

Bruce A Knutson1, Xu Liu, Jaewook Oh, Steven S Broyles.   

Abstract

Vaccinia virus replicates in the cytoplasm of the host cell and encodes its own RNA polymerase and transcription factors. The proteins that target the poxvirus RNA polymerase to intermediate- and late-class promoters have not been identified. In this study, representatives of the intermediate and late promoters were characterized at the nucleotide level to identify essential motifs. Both intermediate and late viral promoters are shown to have an essential element suggestive of TATA boxes, which are potential targets for the TATA-binding protein (TBP). Several approaches were used to test for TBP requirement in vaccinia virus transcription, including overexpression of TBP, expression of a dominant negative mutant of TBP, RNA interference, and expression of adenovirus E1A protein, which inactivates TBP. In each case, the results support an essential role for TBP in vaccinia virus intermediate- and late-gene transcription. These findings indicate that poxviruses have integrated TBP as a central feature into an otherwise heterologous transcription system. A model for transcriptional switching, in which both intermediate and late promoter elements are targeted by TBP that recruits viral transcription factors to assemble a functional complex on their cognate promoters and a dysfunctional, repressed complex on the other class, is proposed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809284      PMCID: PMC1489061          DOI: 10.1128/JVI.02705-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  The genetics of TBP and TBP-related factors.

Authors:  Irwin Davidson
Journal:  Trends Biochem Sci       Date:  2003-07       Impact factor: 13.807

2.  Dominant negative mutations in yeast TFIID define a bipartite DNA-binding region.

Authors:  P Reddy; S Hahn
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

3.  Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters.

Authors:  C J Baldick; J G Keck; B Moss
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  TFIID binds in the minor groove of the TATA box.

Authors:  D B Starr; D K Hawley
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

5.  Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes.

Authors:  J G Keck; C J Baldick; B Moss
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

6.  Transcription factor YY1 is a vaccinia virus late promoter activator.

Authors:  S S Broyles; X Liu; M Zhu; M Kremer
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

7.  Regulation of activity of the yeast TATA-binding protein through intra-molecular interactions.

Authors:  Perumal Vanathi; Anurag Kumar Mishra; Purnima Bhargava
Journal:  J Biosci       Date:  2003-06       Impact factor: 1.826

Review 8.  Vaccinia virus transcription.

Authors:  Steven S Broyles
Journal:  J Gen Virol       Date:  2003-09       Impact factor: 3.891

Review 9.  Unusual life style of giant chlorella viruses.

Authors:  James L Van Etten
Journal:  Annu Rev Genet       Date:  2003       Impact factor: 16.830

10.  Vaccinia virus capping enzyme is a transcription initiation factor.

Authors:  J C Vos; M Sasker; H G Stunnenberg
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

View more
  15 in total

1.  Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.

Authors:  Christine Pugh; Sarah Keasey; Lawrence Korman; Phillip R Pittman; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2014-04-23

2.  Pervasive initiation and 3'-end formation of poxvirus postreplicative RNAs.

Authors:  Zhilong Yang; Craig A Martens; Daniel P Bruno; Stephen F Porcella; Bernard Moss
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

3.  Expression profiling of the intermediate and late stages of poxvirus replication.

Authors:  Zhilong Yang; Sara E Reynolds; Craig A Martens; Daniel P Bruno; Stephen F Porcella; Bernard Moss
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

4.  Identification of Vaccinia Virus Replisome and Transcriptome Proteins by Isolation of Proteins on Nascent DNA Coupled with Mass Spectrometry.

Authors:  Tatiana G Senkevich; George C Katsafanas; Andrea Weisberg; Lisa R Olano; Bernard Moss
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

5.  Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters.

Authors:  Zhilong Yang; Liliana Maruri-Avidal; Jerry Sisler; Carey A Stuart; Bernard Moss
Journal:  Virology       Date:  2013-10-03       Impact factor: 3.616

6.  Vaccinia virus E2L null mutants exhibit a major reduction in extracellular virion formation and virus spread.

Authors:  Arban Domi; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

7.  Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypoxvirus.

Authors:  Jason Farlow; Mohamed Ait Ichou; John Huggins; Sofi Ibrahim
Journal:  Virol J       Date:  2010-05-28       Impact factor: 4.099

8.  Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis.

Authors:  Gilad Sivan; Scott E Martin; Timothy G Myers; Eugen Buehler; Krysia H Szymczyk; Pinar Ormanoglu; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

9.  Barrier to autointegration factor (BAF) inhibits vaccinia virus intermediate transcription in the absence of the viral B1 kinase.

Authors:  Nouhou Ibrahim; April Wicklund; Augusta Jamin; Matthew S Wiebe
Journal:  Virology       Date:  2013-07-24       Impact factor: 3.616

10.  Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates.

Authors:  Jennifer Reinboth; Maria L Ascierto; Nanhai G Chen; Qian Zhang; Yong A Yu; Richard J Aguilar; Rafael Carretero; Andrea Worschech; Yingdong Zhao; Ena Wang; Francesco M Marincola; Aladar A Szalay
Journal:  Hum Gene Ther Methods       Date:  2012-11-06       Impact factor: 2.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.